Year To Quarter End Consolidated Statement Of Comprehensive Income

Immuno-Biological Laboratories Co., Ltd. - Filing #7590343

Concept 2022-04-01 to
2022-06-30
2021-04-01 to
2021-06-30
Year to quarter end consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
-58,937,000 JPY
-110,740,000 JPY
Comprehensive income
-58,937,000 JPY
-110,740,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
-58,937,000 JPY
-110,740,000 JPY
Comprehensive income attributable to non-controlling interests
JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.